Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nerexone SR vs Eperisone HCl in Acute Back Pain
NCT02040415Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Mar 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of DW1030 in acute lumbago and Muscle spasm (2 arms), sponsored by Daewon Pharm. Primary endpoint: Finger-to-Floor Distance at 7 days. Started Mar 2014; status: completed.
02
Drugs
DW1030
03
Conditions
acute lumbagoMuscle spasm
Beyond the preview
Go deeper on NCT02040415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040415.